Award
Delivery Order #75F40126F19008
Delivery Order for Molecular Biology Reagents to QIAGEN under IDIQ Contract
Buyer
Food and Drug Administration
Award Amount
$137,961.14
Ceiling
$137,961.14
Awarded
June 01, 2026
Period of Performance
Jun 01, 2026 – Sep 30, 2026
Identifier
75F40126F19008
NAICS
325413
This award represents a delivery order contract issued to QIAGEN, LLC, a U.S.-owned company specializing in molecular biology and sequencing technology, under a previously established Indefinite Delivery Indefinite Quantity (IDIQ) contract. The purpose of this order is the procurement of molecular biology reagents essential for laboratory research and testing. This contract supports the ongoing efforts of the Department of Health and Human Services, particularly enhancing capabilities at the U.S. Food and Drug Administration, by providing critical biological reagents needed for health-related scientific analysis. The work involves supplying specific molecular biology and sequencing library reagents as per the terms of the overarching IDIQ agreement. The award was made as a sole-source delivery order, relying on QIAGEN's specialized expertise and product offerings. The order is set to be performed over a multi-month timeframe, reflecting a short-term but substantial supply need. It is a continuation of the broader IDIQ contract initially awarded in mid-2021, which has established a framework for multiple such orders to fulfill laboratory service requirements.
Description
ORDER AGAINST 75F40121D00009 QIAGEN IDIQ FOR PURCHASE OF MOLECULAR BIOLOGY REAGENTS.